Study on Vascular Function, Sarcopenia and Pain in Treated Postmenopausal Osteoporosis
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 50
Healthy Volunteers: f
View:
• Women aged 50 years or older with postmenopausal osteoporosis, whether fractured or not, requiring initiation of treatment with antiosteoporotic drugs (bisphosphonates, raloxifene, teriparatide, denosumab and others to come for this indication, including romosozumab), either orally or by injection, as part of their care and management.
• Able to give informed consent to participate in research.
• Affiliation to a Social Security system.
Locations
Other Locations
France
CHU de Clermont-Ferrand
RECRUITING
Clermont-ferrand
Contact Information
Primary
Lise LACLAUTRE
promo_interne_drci@chu-clermontferrand.fr
+33473754963
Time Frame
Start Date: 2022-02-15
Estimated Completion Date: 2027-02-01
Participants
Target number of participants: 150
Treatments
Other: Cohort follow-up
Exploratory study involving functional explorations in longitudinal follow-up, initiated in parallel with a treatment indicated in the patient's usual care and management.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Clermont-Ferrand